Cargando…

Reciprocal regulation of miR‐206 and IL‐6/STAT3 pathway mediates IL6‐induced gefitinib resistance in EGFR‐mutant lung cancer cells

Persistently activated IL‐6/STAT3 pathway promotes acquired resistance to targeted therapy with epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs) in non–small‐cell lung cancer (NSCLC) treatment. miR‐206 has been verified to be dysregulated and plays as a negative regulator in l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yanhua, Wang, Wei, Chang, Hong, Han, Zenglei, Yu, Xinjuan, Zhang, Tingguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815809/ https://www.ncbi.nlm.nih.gov/pubmed/31507089 http://dx.doi.org/10.1111/jcmm.14592

Ejemplares similares

Extracellular Vesicle miR-200c Enhances Gefitinib Sensitivity in Heterogeneous EGFR-Mutant NSCLC
por: Lin, Chien-Chung, et al.
Publicado: (2021)

Soluble IL6R represents a miR-34a target: potential implications for the recently identified IL-6R/STAT3/miR-34a feed-back loop
por: Li, Huihui, et al.
Publicado: (2015)

Dual inhibition of EGFR and IL-6-STAT3 signalling by miR-146b: a potential targeted therapy for epithelial ovarian cancer
por: Yan, Meina, et al.
Publicado: (2021)

Expression of miRNAs miR-133b and miR-206 in the Il17a/f Locus Is Co-Regulated with IL-17 Production in αβ and γδ T Cells
por: Haas, Jan D., et al.
Publicado: (2011)

Serum miR-17, IL-4, and IL-6 levels for diagnosis of endometriosis
por: Wang, Fang, et al.
Publicado: (2018)

MiR-125a-5p Decreases the Sensitivity of Treg cells Toward IL-6-Mediated Conversion by Inhibiting IL-6R and STAT3 Expression
por: Li, Dan, et al.
Publicado: (2015)

Dual STAT-3 and IL-6R inhibition with stattic and tocilizumab decreases migration, invasion and proliferation of prostate cancer cells by targeting the IL-6/IL-6R/STAT-3 axis
por: Méndez-Clemente, Anibal, et al.
Publicado: (2022)

miR-146a, miR-146b, and miR-155 increase expression of IL-6 and IL-8 and support HSP10 in an In vitro sepsis model
por: Pfeiffer, Dagmar, et al.
Publicado: (2017)

miR-320 accelerates chronic heart failure with cardiac fibrosis through activation of the IL6/STAT3 axis
por: Li, Fang, et al.
Publicado: (2021)

Hsa_circ_0017728 as an oncogene in gastric cancer by sponging miR-149 and modulating the IL-6/STAT3 pathway
por: Yang, Chun, et al.
Publicado: (2019)

IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells
por: Zhu, Xiaolan, et al.
Publicado: (2017)

Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal pathway in Gefitinib-resistant lung cancer cells
por: Cao, Wei, et al.
Publicado: (2015)

Activating IL-6/STAT3 Enhances Protein Stability of Proteasome 20S α+β in Colorectal Cancer by miR-1254
por: Ren, Weiguo, et al.
Publicado: (2022)

Correction for: miR-320 accelerates chronic heart failure with cardiac fibrosis through activation of the IL6/STAT3 axis
por: Li, Fang, et al.
Publicado: (2023)

MCL-1 is modulated in Crohn’s disease fibrosis by miR-29b via IL-6 and IL-8
por: Nijhuis, Anke, et al.
Publicado: (2017)

IL-6-STAT3 signaling and premature senescence
por: Kojima, Hirotada, et al.
Publicado: (2013)

miR‐1‐3p and miR‐206 sensitizes HGF‐induced gefitinib‐resistant human lung cancer cells through inhibition of c‐Met signalling and EMT
por: Jiao, Demin, et al.
Publicado: (2018)

miR-196b-5p-mediated downregulation of FAS promotes NSCLC progression by activating IL6-STAT3 signaling
por: Huang, Xiangjie, et al.
Publicado: (2020)

Association of Polymorphisms of IL-6 Pathway Genes (IL6, IL6R and IL6ST) with COVID-19 Severity in an Amazonian Population
por: Rodrigues, Fabíola Brasil Barbosa, et al.
Publicado: (2023)

Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3
por: Yue, Jinnan, et al.
Publicado: (2018)

FAIM Is Regulated by MiR-206, MiR-1-3p and MiR-133b
por: Coccia, Elena, et al.
Publicado: (2020)

Butein Inhibits Cell Growth by Blocking the IL-6/IL-6Rα Interaction in Human Ovarian Cancer and by Regulation of the IL-6/STAT3/FoxO3a Pathway
por: Park, Sun-Ae, et al.
Publicado: (2023)

IL-6, IL-17 and Stat3 are required for auto-inflammatory syndrome development in mouse
por: Oike, Takatsugu, et al.
Publicado: (2018)

IL-6 Inhibits the Targeted Modulation of PDCD4 by miR-21 in Prostate Cancer
por: Dong, Biao, et al.
Publicado: (2015)

The critical function of miR-1323/Il6 axis in children with Mycoplasma pneumoniae pneumonia
por: Yin, Linlin, et al.
Publicado: (2020)

IL-6, IL-12, and IL-23 STAT-Pathway Genetic Risk and Responsiveness of Lymphocytes in Patients with Multiple Sclerosis
por: von Essen, Marina R., et al.
Publicado: (2019)

MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8
por: Bhaumik, Dipa, et al.
Publicado: (2009)

MiR-21-5p protects against ischemic stroke by targeting IL-6R
por: Zhan, Lan, et al.
Publicado: (2023)

Epithelial miR-206 targets CD39/extracellular ATP to upregulate airway IL-25 and TSLP in type 2–high asthma
por: Zhang, Kan, et al.
Publicado: (2021)

Sulforaphane improves chemotherapy efficacy by targeting cancer stem cell-like properties via the miR-124/IL-6R/STAT3 axis
por: Wang, Xingxing, et al.
Publicado: (2016)

Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway
por: Leng, Kaiming, et al.
Publicado: (2019)

Microarray profiling of L1-overexpressing endothelial cells reveals STAT3 activation via IL-6/IL-6Rα axis
por: Magrini, Elena, et al.
Publicado: (2015)

IL6/IL6R genetic diversity and plasma IL6 levels in bipolar disorder: An Indo-French study
por: Sundaresh, Aparna, et al.
Publicado: (2019)

Dissecting the IL‐6 pathway in cardiometabolic disease: A Mendelian randomization study on both IL6 and IL6R
por: Cupido, Arjen J., et al.
Publicado: (2022)

STAT3 activation by KSHV correlates with IL-10, IL-6 and IL-23 release and an autophagic block in dendritic cells
por: Santarelli, Roberta, et al.
Publicado: (2014)

IL-17 Promotes Angiogenic Factors IL-6, IL-8, and Vegf Production via Stat1 in Lung Adenocarcinoma
por: Huang, Qi, et al.
Publicado: (2016)

IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
por: Wang, Lin, et al.
Publicado: (2009)

Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis
por: Chen, Xiao-Wu, et al.
Publicado: (2015)

Novel Small Molecule Inhibitors Targeting the IL-6/STAT3 Pathway or IL-1β
por: Yoo, Jihye, et al.
Publicado: (2022)

Correlation of myomir-206 and proinflammatory cytokines (IL-16 and IL-17) in patients with rheumatoid arthritis
por: ElAtta, Amira Abo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o5s7qff7h5sb9006kuan8f6upv